• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Saturday, October 11, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News

Study identifies a role for the metabolism regulator PPARγ in liver cancer

Bioengineer by Bioengineer
April 10, 2017
in Science News
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Liver cancers are a major cause of cancer-related deaths. Large-scale genetic analyses have associated liver cancer with dysregulation of numerous molecular pathways, but disruptions in insulin signaling pathways appear to have a particularly important contribution to liver tumor formation. Obesity is a major risk factor for developing liver cancer, and the nuclear receptor PPARγ critically controls fat uptake and storage in the liver by regulating the transcription of metabolism-associated genes. However, whether PPARγ also plays a role in promoting the growth of liver tumors is not clear.

This week in the JCI, research led by Ganna Panasyuk at INSERM examined the link between PPARγ and liver tumor formation. The findings identify a metabolic pathway with pro-tumor effects that can be suppressed by selectively blocking PPARγ. Researchers initially observed that increases in PPARγ expression and activity in human liver tumors were associated with loss-of-function of the transcription factor hepatocyte nuclear factor 1α (HNF1α). In a mouse model, they determined that loss of HNF1α led to abnormal increases in PPARγ expression that in turn led to increased tumorigenesis. Pharmacological activation of PPARγ in a mouse model of liver cancer exacerbated tumor formation; in contrast, treatment with a PPARγ inhibitor had positive therapeutic effects.

Taken together, these findings demonstrate a role for PPARγ in the metabolic pathway disturbances that promote liver tumorigenesis and reveal that PPARγ is a potential target for anti-tumor therapies to treat liver cancers.

###

TITLE: Hepatocyte nuclear factor 1α suppresses steatosis- associated liver cancer by inhibiting PPARγ transcription

AUTHOR CONTACT:

Ganna Panasyuk
Institut Necker-Enfants Malades
INSERM U1151/CNRS UMR 8253 a href="mailto:[email protected]">[email protected]

View this article at: http://www.jci.org/articles/view/90327?key=f53576a87fd0165f5cb7

Media Contact

Elyse Dankoski
[email protected]
@jclinicalinvest

http://www.jci.org

############

Story Source: Materials provided by Scienmag

Share12Tweet7Share2ShareShareShare1

Related Posts

Easing Caregiver Stress for Heart Surgery Families

October 11, 2025
Essential Role of Negative Training Data in Antibody Predictions

Essential Role of Negative Training Data in Antibody Predictions

October 11, 2025

Unveiling Kidney Functions with Spatial Proteomics

October 11, 2025

New Framework Uncovers Differential Chromatin Interactions

October 11, 2025
Please login to join discussion

POPULAR NEWS

  • Sperm MicroRNAs: Crucial Mediators of Paternal Exercise Capacity Transmission

    1207 shares
    Share 482 Tweet 301
  • New Study Reveals the Science Behind Exercise and Weight Loss

    102 shares
    Share 41 Tweet 26
  • New Study Indicates Children’s Risk of Long COVID Could Double Following a Second Infection – The Lancet Infectious Diseases

    97 shares
    Share 39 Tweet 24
  • Revolutionizing Optimization: Deep Learning for Complex Systems

    86 shares
    Share 34 Tweet 22

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Easing Caregiver Stress for Heart Surgery Families

Essential Role of Negative Training Data in Antibody Predictions

Unveiling Kidney Functions with Spatial Proteomics

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 63 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.